ATE86491T1 - Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. - Google Patents

Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.

Info

Publication number: ATE86491T1
Authority: AT; Austria
Prior art keywords: treatment; diseases; entertain; medication; manufacture
Prior art date: 1986-12-24

Application number

AT87311250T

Other languages

English (en)

Inventor

David Anthony Richards

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-24

Filing date

1987-12-21

Publication date

1993-03-15

1987-12-21 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1993-03-15 Application granted granted Critical

1993-03-15 Publication of ATE86491T1 publication Critical patent/ATE86491T1/de

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
229960000289 fluticasone propionate Drugs 0.000 title abstract 2
WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT87311250T 1986-12-24 1987-12-21 Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. ATE86491T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868630913A GB8630913D0 (en)	1986-12-24	1986-12-24	Pharmaceutical compositions
EP87311250A EP0278174B1 (de)	1986-12-24	1987-12-21	Verwendung von Fluticasonpropionat zur Herstellung eines Präparats zur Behandlung von Darmerkrankungen

Publications (1)

Publication Number	Publication Date
ATE86491T1 true ATE86491T1 (de)	1993-03-15

Family

ID=10609600

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87311250T ATE86491T1 (de)	1986-12-24	1987-12-21	Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.

Country Status (13)

Country	Link
US (1)	US4985418A (de)
EP (1)	EP0278174B1 (de)
JP (1)	JPS63233998A (de)
KR (1)	KR880007084A (de)
AT (1)	ATE86491T1 (de)
AU (1)	AU8296987A (de)
CA (1)	CA1302262C (de)
DE (1)	DE3784693T2 (de)
DK (1)	DK678887A (de)
ES (1)	ES2053571T3 (de)
GB (2)	GB8630913D0 (de)
NZ (1)	NZ223045A (de)
ZA (1)	ZA879464B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5270305A (en) *	1989-09-08	1993-12-14	Glaxo Group Limited	Medicaments
US5208226A (en) *	1989-09-08	1993-05-04	Glaxo Group Limited	Medicaments
SE8903914D0 (sv) *	1989-11-22	1989-11-22	Draco Ab	Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) *	1989-11-22	1997-07-01	Astra Aktiebolag	Oral composition for the treatment of inflammatory bowel disease
IT1256061B (it) *	1992-11-20	1995-11-23		Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
US6166024A (en) *	1995-03-30	2000-12-26	Mayo Foundation For Medical Education And Research	Use of topical azathioprine and thioguanine to treat colorectal adenomas
NL1006774C2 (nl) *	1996-08-14	1998-09-28	Univ Potchefstroom	Anti-atherosclerose- en anti-trombotisch middel en het gebruik daarvan.
DE19732903A1 (de)	1997-07-30	1999-02-04	Falk Pharma Gmbh	Pellet-Formulierung zur Behandlung des Intestinaltraktes
US5993782A (en) *	1998-04-28	1999-11-30	Gardner; Conrad O.	Therapeutic method for reversing hyposmia in a human patient
EP1075267A2 (de) *	1998-05-06	2001-02-14	Kobenhavns Universitet	Behandlung der zöliakie (einheimische sprue)
GB9823036D0 (en) *	1998-10-22	1998-12-16	Glaxo Group Ltd	Fluticasone lotion having improved vasoconstrictor activity
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050009848A1 (en) *	2003-07-10	2005-01-13	Icn Pharmaceuticals Switzerland Ltd.	Use of antivirals against inflammatory bowel diseases
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en)	2005-11-12	2012-12-04	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en)	2005-11-12	2014-03-25	The Regents Of The University Of California	Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US9050368B2 (en) *	2007-11-13	2015-06-09	Meritage Pharma, Inc.	Corticosteroid compositions
HUE038452T2 (hu)	2007-11-13	2018-10-29	Meritage Pharma Inc	Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók
US20100216754A1 (en) *	2007-11-13	2010-08-26	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
WO2010040113A1 (en)	2008-10-03	2010-04-08	Salix Pharmaceuticals, Ltd.	Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2010144865A2 (en) *	2009-06-12	2010-12-16	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
EP2482822B1 (de)	2009-10-01	2018-08-01	Adare Pharmaceuticals, Inc.	Oral verabreichte corticosteroid-zusammensetzungen
WO2015034678A2 (en)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CA2936741C (en)	2014-10-31	2018-11-06	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
TWI777515B (zh)	2016-08-18	2022-09-11	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE887518A (fr) *	1980-02-15	1981-08-13	Glaxo Group Ltd	Cartothioates d'androstanes
GB2088877B (en) *	1980-02-15	1984-07-04	Glaxo Group Ltd	Androstane 17 carbothioates
US4578221A (en) *	1980-04-23	1986-03-25	Glaxo Group Limited	Androstane carbothioic acids
US4710495A (en) *	1980-07-10	1987-12-01	Otsuka Pharmaceutical Co., Ltd.	Soft steroids having anti-inflammatory activity

1986
- 1986-12-24 GB GB868630913A patent/GB8630913D0/en active Pending
1987
- 1987-12-17 ZA ZA879464A patent/ZA879464B/xx unknown
- 1987-12-21 EP EP87311250A patent/EP0278174B1/de not_active Expired - Lifetime
- 1987-12-21 GB GB8729756A patent/GB2199747B/en not_active Expired - Fee Related
- 1987-12-21 ES ES87311250T patent/ES2053571T3/es not_active Expired - Lifetime
- 1987-12-21 DE DE8787311250T patent/DE3784693T2/de not_active Expired - Fee Related
- 1987-12-21 AT AT87311250T patent/ATE86491T1/de not_active IP Right Cessation
- 1987-12-22 NZ NZ223045A patent/NZ223045A/xx unknown
- 1987-12-22 DK DK678887A patent/DK678887A/da not_active Application Discontinuation
- 1987-12-23 JP JP62324203A patent/JPS63233998A/ja active Pending
- 1987-12-23 US US07/137,169 patent/US4985418A/en not_active Expired - Lifetime
- 1987-12-23 AU AU82969/87A patent/AU8296987A/en not_active Abandoned
- 1987-12-23 CA CA000555200A patent/CA1302262C/en not_active Expired - Lifetime
- 1987-12-24 KR KR870014856A patent/KR880007084A/ko not_active Ceased

Also Published As

Publication number	Publication date
US4985418A (en)	1991-01-15
DK678887A (da)	1988-06-25
GB2199747A (en)	1988-07-20
DK678887D0 (da)	1987-12-22
EP0278174A2 (de)	1988-08-17
GB2199747B (en)	1990-10-24
DE3784693D1 (de)	1993-04-15
NZ223045A (en)	1989-11-28
ES2053571T3 (es)	1994-08-01
GB8729756D0 (en)	1988-02-03
AU8296987A (en)	1988-06-30
DE3784693T2 (de)	1993-06-17
JPS63233998A (ja)	1988-09-29
ZA879464B (en)	1988-12-28
EP0278174A3 (en)	1990-06-27
EP0278174B1 (de)	1993-03-10
GB8630913D0 (en)	1987-02-04
KR880007084A (ko)	1988-08-26
CA1302262C (en)	1992-06-02

Similar Documents

Publication	Publication Date	Title
DE3784693D1 (de)	1993-04-15	Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE3772429D1 (de)	1991-10-02	Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
ATE82121T1 (de)	1992-11-15	Arzneimittel fuer die therapeutische behandlung von alopezie.
DE68923819D1 (de)	1995-09-21	Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE83659T1 (de)	1993-01-15	Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3775805D1 (de)	1992-02-20	Arzneimittel zur behandlung periodontaler erkrankungen.
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
ATE144142T1 (de)	1996-11-15	Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
DE3776946D1 (de)	1992-04-09	Nasale verabreichung von arzneimitteln.
DE69824576D1 (de)	2004-07-22	Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
ATE191849T1 (de)	2000-05-15	Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE69130586D1 (de)	1999-01-21	Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE60029929D1 (de)	2006-09-21	VERWENDUNG VON PYRIDAZINO i4,5-(b)ö-INDOLE-1-ACETAMIDE DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON DURCH PERIPHERE BENZODIAZEPINREZEPTOREN-STÖRUNGEN VERURSACHTE KRANKHEITEN
DE69233725D1 (de)	2008-03-27	Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
ATE132749T1 (de)	1996-01-15	Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ATE74605T1 (de)	1992-04-15	Tetracyclische chinazolinderivate, herstellung und verwendung.
DE69007065D1 (de)	1994-04-07	Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE69716341D1 (de)	2002-11-21	Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE69023459D1 (de)	1995-12-14	Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE96024T1 (de)	1993-11-15	Thiosulfinsaeurederivate, und die verwendung von thiosulfinsaeurederivaten zur herstellung von arzneimitteln fuer die behandlung von entzuendungserkrankungen.
DE69300037D1 (de)	1995-02-09	Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
FI925546A7 (fi)	1992-12-07	Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
DE69124415D1 (de)	1997-03-13	Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen

Legal Events

Date	Code	Title	Description
1993-08-15	UEP	Publication of translation of european patent specification
1995-03-15	REN	Ceased due to non-payment of the annual fee